CE Celanese Corp

$51.18 -0.08%

Healthcare · Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)

Celanese Corp (CE) is a healthcare company in the Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) industry, with a market capitalization of $5.6 billion. Shares last traded at $51.18, 27.6% below their 52-week high. Over the past year the stock is down 6.1%. Net profit margin is -12.2%, below the peer median of 0.0%. Revenue declined 7.1% year over year.

Market Cap

$5.6B

Shares Out

109.7M

EPS (TTM)

$-9.01

P/E Ratio

—

P/S Ratio

0.59

P/B Ratio

1.38

Dividend / Share

—

Dividend Yield

—

52-Week High

$70.67

52-Week Low

$35.14

Volume

55,259

Avg Vol (3m)

136,318.984

Performance

-0.95%

-4.30%

-15.11%

+24.98%

YTD

+21.39%

-6.07%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

39.93

SMA (50)

$58.67

SMA (200)

$49.67

Price vs SMA50

-12.76%

Price vs SMA200

+3.05%

ATR (14)

$2.18

Financials

Revenue

$9.5B

Net Income

$-1165M

Gross Margin

20.5%

Operating Margin

-8.2%

Net Margin

-12.2%

Return on Equity

-28.7%

Return on Assets

-5.4%

Current Ratio

1.38

Debt / Equity

3.10

Revenue Growth (YoY)

-7.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.40	2026-05-06
FY 2025	$-10.64	2026-02-24
Q3 2025	$-10.81	2025-11-07
Q2 2025	$1.62	2025-08-11
Q1 2026	$-0.22	2026-05-06
FY 2025	$-14.11	2026-02-24

Full earnings history →

Healthcare peers

CE vs 14 sector peers (Healthcare), by market cap.

P/S vs peers

0.59 / 2.59 med

-77% discount

Net margin vs peers

-12.2% / 0.0% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
LIN	Linde	$236.9B	34.34	6.97	20.3%	-0.75%
AMGN	Amgen	$182.1B	23.62	4.96	21.0%	-1.27%
TMO	Thermo Fisher Scientific	$172.7B	25.70	3.88	15.1%	+0.67%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
GILD	Gilead Sciences	$153.5B	18.04	5.21	28.9%	-1.46%
ISRG	Intuitive Surgical	$144.0B	50.41	14.30	28.4%	+1.06%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
DHR	Danaher Corporation	$125.4B	34.70	5.10	14.7%	-0.38%
SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.